[Ip-health] Infojustice Roundup – September 19, 2016

Michael Palmedo mpalmedo at wcl.american.edu
Mon Sep 19 07:02:33 PDT 2016

Infojustice Roundup


Report of the UN Secretary-General’s High-Level Panel on Access to Medicines: Promoting Innovation and Access to Health Technologies

[United Nations] ... Secretary-General Ban Ki-moon, in November 2015, announced the appointment of a High-Level Panel on Innovation and Access to Health Technologies. In keeping with the commitment of United Nations Member States to enhance policy coherence for sustainable development, the High-Level Panel’s terms of reference called for it to “review and assess proposals and recommend solutions for remedying the policy incoherence between the justifiable rights of inventors, international human rights law, trade rules and public health in the context of health technologies,” among other things. In accordance with the principle of universality that underpins the 2030 Agenda and its aspiration to leave no one behind, the High-Level Panel views innovation and access to health technologies as a multi-dimensional and global problem that affects all countries. Click here for more.<http://infojustice.org/archives/36908>

See also:  Statements by the Treatment Action Campaign<http://tac.org.za/news/un-report-strengthens-case-patent-law-reform-sa-and-other-developing-countries>, Knowledge Ecology International<http://keionline.org/node/2626>, Médecins Sans Frontières<http://www.msfaccess.org/content/msf-response-report-un-secretary-generals-high-level-panel-access-medicines>, Oxfam<http://www.oxfam.org.uk/media-centre/press-releases/2016/09/governments-must-act-on-new-un-report-to-bring-down-the-cost-of-medicines-says-oxfam>, Canadian HIV/AIDS Legal Network<http://www.aidslaw.ca/site/un-high-level-panel/?lang=en>, Health GAP<http://www.healthgap.org/hlpreport>, Drugs for Neglected Diseases Initiative<http://www.dndi.org/2016/advocacy/dndi-response-unhlp-report/>, Health Action International<http://haiweb.org/publication/health-action-international-response-report-un-high-level-panel-access-medicines/>, United States Chamber of Commerce<http://www.theglobalipcenter.com/u-s-chamber-condemns-un-report-attacking-patents/>,  Pharmaceutical Research and Manufacturers of America<http://phrma.org/press-release/phrma-statement-on-the-united-nations-high-level-panel-report-on-access-to-medicines>, International Federation of Pharmaceutical Manufacturers & Associations<http://www.ifpma.org/resource-centre/biopharmaceutical-industry-calls-the-recommendations-of-un-high-level-panel-on-access-to-medicines-a-missed-opportunity-to-genuinely-address-patients-needs/>, Biotechnology Innovation Organization<https://www.bio.org/press-release/bio-statement-regarding-un-high-level-panel-access-medicines-report>, and the U.S. Department of State<http://www.state.gov/r/pa/prs/ps/2016/09/262034.htm>.

Big Pharma’s Court Cases in Brazil & Argentina Threaten to Dismantle the National Laws Considered as Important Public Health Safeguards in the UN High Level Panel Report

[Joint statement by Fundación Grupo Efecto Positivo and the ABIA Grupo de Trabalho sobre Propriedade Intelectual] The United Nation’s High Level Panel (UN HLP) on Access to Medicines released yesterday its final report. ... Although the recommendations of the report could have been stronger, it clearly recommends the use of pro public health safeguards to promote the human right to health. The report describes some of the challenges faced by countries to make use of those safeguards, however it fails on addressing the responsibility of pharmaceutical companies. Court cases filed by Big Pharma in Brazil and Argentina are threatening the access to medicines, and acting against the recommendations of the UN HLP.  Click here for more.<http://infojustice.org/archives/36928>

Protecting Online Access to Safe and Affordable Medication

...[Gabriel Levitt] There is plenty of discussion about the safety of ordering medications online. While rogue and illegal online pharmacies are dangerous and need to be stopped, the online marketplace is complex and potentially misunderstood by thought leaders in Internet governance, which can lead to the acceptance of rules that hinder access to affordable medication. The Internet community has a unique opportunity to play a role in pushing back against unjust pharmaceutical-industry interests and Internet censorship: and even protecting human rights. Click here for more.<http://infojustice.org/archives/36938>

Cato Institute on the “Protectionist” Intellectual Property Provisions in the Trans Pacific Partnership

[Mike Palmedo] The Cato Institute has released a report that “presents a chapter-by-chapter analysis of the Trans Pacific Partnership (TPP) from a free trader’s perspective.” It notes that TPP is really more of a “managed” or “freer” trade agreement than an agreement that really promotes “free trade” in a classic sense. It finds that overall, the “terms of the TPP are net liberalizing,” but that some of the individual chapters – including the intellectual property chapter – are actually “protectionist.” Click here for more.<http://infojustice.org/archives/36915>


More information about the Ip-health mailing list